KLR Keller Group plc
Keller Group plc provides specialist geotechnical services in North America, Europe, the Middle East, and the Asia-Pacific. The company offers ground engineering solutions, including ground improvement services, grouting, deep foundations, earth retention, marine, and instrumentation and monitoring services, as well as post-tension systems and industrial services. It also provides bearing capacity/ settlement control, low carbon construction, containment, excavation support, stabilization, marine structures, seepage control, slope stabilization, and monitoring solutions. In addition, it provides environmental remediation and demolition. The company provides its services to the construction sector in commercial, industrial, infrastructure, institutional/public buildings, power, and residential markets. Keller Group plc was founded in 1860 and is headquartered in London, the United Kingdom.…
Industry Peers
Engineering & ConstructionKey Statistics
About Keller Group (LON: KLR)
›
Keller Group (LON: KLR) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Engineering & Construction industry, part of the Industrials sector, and reports about 10,000 employees.
The shares were at 2916.00 GBp on 20 November 2026, up 91.5% over 52 weeks. Its 52-week range is 1490.00 GBp to 3518.00 GBp: the price is 17.1% below the high and 95.7% above the low.
At a market capitalisation of 1.96B GBP, it trades at 13.4 times trailing earnings and 10.9 times forward earnings. The median trailing P/E of its 19 largest Engineering & Construction peers is 24.1, a discount of 44% for KLR. It pays a dividend yielding 2.72% (it pays out 32% of its earnings), against a median of 2.25% among the dividend payers in that peer group.
Keller Group reports return on equity of 22.2%, an operating margin of 7.0% and revenue up 10.3% year over year.
Its debt exceeds its cash by 102.60M GBP, a debt-to-equity ratio of 0.48. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 7 analysts cover the stock, with an average rating of Buy; their mean price target of 3524.29 GBp is 20.9% above the current price. The next earnings report is expected on 18 March 2027.